English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/58954
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Anti.-tumor activity of FGFR3-specific immunotoxins in a xenograft mouse model of bladder carcinoma

AuthorsMartínez-Torrecuadrada, Jorge Luis; Cheung, L.H.; Lopez-Serra, P.; Barderas, Rodrigo ; Cañamero, Marta; Ferreiro, Sergio; Rosenblum, M.G.; Casal, J. Ignacio
KeywordsFGFR3
Immuno toxins
Bladder carcinoma tumor
Growth inhibition
Apoptosis
Issue DateApr-2008
PublisherAmerican Association for Cancer Research
CitationMolecular Cancer Therapeutics, 7 (4) : 862-873 (2008)
AbstractHuman single-chain Fv directed against fibroblast growth factor receptor 3 (FGFR3) have been shown to block proliferation of RT112 bladder carcinoma cells in vitro. Here, we examined the ability of the recombinant gelonin toxin (rGel) to enhance this inhibitory effect in vitro and in vivo on the bladder cancer cell line RT112 and the corresponding xenografts. Immunotoxins were genetically engineered by fusing FGFR3-specific Fv fragments (3C) to the NH2 terminus of rGel and expressed as a soluble protein in Escherichia coli. The 3C/rGel fusion construct showed an IC50 of 200 nmol/L against log-phase RT112 cells compared with 1,500 nmol/L for free rGel. Immunofluorescence studies showed that the 3C/rGel construct internalized rapidly into the cytoplasm of RT112 cells within 1 h of exposure. The mechanism of immunotoxin-induced cell death was found to be mediated by apoptosis. RT112 tumor xenografts in severe combined immunodeficient mice treated with 50 mg/kg 3C/rGel exhibited considerable growth delay relative to control tumors and a significant reduction of 55% to 70% in mean tumor size. Immunohistochemical analysis showed that tumors from mice treated with 3C/rGel displayed considerable apoptotic damage compared with control groups. Subcellular location of FGFR3 in immunotoxin-treated tumors indicated a translocation of FGFR3 to the nuclear membrane in contrast to tumors from saline-treated controls. These results show that FGFR3-driven immunotoxins may be an effective therapeutic agent against human bladder and other tumor types overexpressing FGFR3
Description12 páginas, 6 figuras -- PAGS nros. 462-473
Publisher version (URL)http://dx.doi.org/10.1158/1535-7163.MCT-07-0394
URIhttp://hdl.handle.net/10261/58954
DOI10.1158/1535-7163.MCT-07-0394
ISSN1535-7163
E-ISSN1538-8514
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.